Trial Details

TERMINATED
Basic Information
Clinical ID c2448
Identifier NCT03467958
Trial Title An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Crohn Disease
Interventions DRUG: Ozanimod
Participant Information
Sponsor Celgene
City Peoria
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2018-08-24
Primary Completion Date 2024-10-31
Completion Date 2024-10-31